BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Memento EPFL//
BEGIN:VEVENT
SUMMARY:Society for Immunotherapy of Cancer - 2024 Fellowships
DTSTART;VALUE=DATE:20240318
DTSTAMP:20260916T212132Z
UID:7aee5cb94164d70a20cb416887b59b0d338fbc71bdff37e61fa81b51
CATEGORIES:Conferences - Seminars
DESCRIPTION:The Society for Immunotherapy of Cancer’s (SITC) Fellowships
  program supports the development of early career scientists in the field 
 to cultivate the next generation of cancer immunotherapy experts.\n\nPleas
 e note that applicants must be current SITC members.\n\nIn 2024\, four fel
 lowship programs are open to international applicants.\n\nSITC-Bristol Mye
 rs Squibb Postdoctoral Cancer Immunotherapy Translational Fellowship\nThis
  cancer immunotherapy translational fellowship aims to support an MD\, PhD
 \, or combined MD/PhD individual with a vested interest in furthering the 
 research and translation of cancer immunotherapy.\n\n	Funding:  $200\,000
 \n	Duration: 2 years\n	Eligibility: Hold an MD\, PhD or combined MD/PhD de
 gree\, currently in a postdoc or comparable position\, and have a pre-arra
 nged fellowship mentor.\n	Full info here\n\n\nSITC-MRA Women in Melanoma F
 ellowship \nThis fellowship supports a woman who has an MD\, PhD\, or comb
 ined MD/PhD degree with a vested interest in furthering research in cancer
  immunotherapy for the treatment of patients with melanoma.\n\n	Funding: 
  $200\,000\n	Duration: 2 years\n	Eligibility: Hold an MD\, PhD or combined
  MD/PhD degree\, currently hold a position at an academic institution as a
 n Assistant Professor (or equivalent) and be within four years of appointm
 ent\n	Full info here\n\n\nSITC-Merck Cancer Immunotherapy Clinical Fellows
 hip\nThis clinical fellowship supports an MD or combined MD/PhD with a ves
 ted interest in furthering cancer immunotherapy research and translational
  immunotherapeutic approaches.\n\n	Funding:  $100\,000\n	Duration: 1 year
 \n	Eligibility: Hold an MD or combined MD/PhD\, currently hold a postdoc o
 r tenure-track position\, have a pre-arranged fellowship mentor\n	Full inf
 o here\n\n\nSITC-Mallinckrodt Pharmaceuticals Adverse Events in Cancer Imm
 unotherapy Clinical Fellowship\nThis fellowship provides support to an ind
 ividual with an MD (or equivalent) or combined MD/PhD degree with a vested
  interest in furthering the research and translation of adverse events in 
 cancer immunotherapy.\n\n	Funding:  $40\,000\n	Duration: 1 year\n	Eligibi
 lity: Hold an MD or combined MD/PhD\, currently hold a postdoc or tenure-t
 rack position\, have a pre-arranged fellowship mentor.\n	Full info here\n\
 n\nHow to Apply: Applications are submitted through dedicated online platf
 orms: for the SITC-Bristol Myers Squibb Postdoctoral Cancer Immunotherapy 
 Translational Fellowship\, SITC-MRA Women in Melanoma Fellowship and SITC-
 Merck Cancer Immunotherapy Clinical Fellowship the portal can be found he
 re. For the The SITC-Mallinckrodt Pharmaceuticals Adverse Events in Cancer
  Immunotherapy Clinical Fellowship the portal can be found here.\n\nAppli
 cation Deadline: 18 March 2024\n\nFurther information\n\n\n	More informati
 on about the program is available here.\n	The application portals can be f
 ound here and here.\n	For any other questions\, please contact the Researc
 h Office\n
LOCATION:
STATUS:CONFIRMED
END:VEVENT
END:VCALENDAR